Testing effectiveness (Phase 2)Not Yet RecruitingNCT07613359
What this trial is testing
Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant
Who this might be right for
Antibody-Mediated Rejection (AMR)
Takeda 36